Sign in to view content

Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2022

Related

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes From the Randomized RECOVERY Trial
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2019
Disparities in Utilization, Payments, and Follow-up of Teleophthalmology for Remote Diabetic Retinopathy Screening
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2024
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024

Category: Diabetic Retinopathy

See more